CARIBOU BIOSCIENCES INC (CRBU) Stock Balance Sheet
NASDAQ:CRBU - Nasdaq - US1420381089 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 31.97M | 51.16M | 58.30M | 240.40M | 16.00M | |||
| Marketable Securities | 196.21M | 277.67M | 189.30M | 135.40M | 0.00 | |||
| Receivables | 2.67M | 3.86M | 4.70M | 8.10M | 5.20M | |||
| Other Current Assets | 6.58M | 6.15M | 7.90M | 7.30M | 3.20M | |||
| Total Current Assets | 237.43M | 338.84M | 260.20M | 391.20M | 24.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 40.06M | 40.45M | 34.90M | 4.90M | 3.50M | |||
| Investments And Advances | 62.11M | 51.33M | 77.10M | 45.30M | 7.60M | |||
| Other Non-Current Assets | 4.74M | 1.59M | 1.50M | 1.00M | 600.00K | |||
| Total Non-Current Assets | 106.91M | 93.37M | 113.60M | 51.20M | 11.70M | |||
| TOTAL ASSETS | 344.33M | 432.21M | 373.80M | 442.40M | 36.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 700.00K | |||
| Accrued Expenses | 25.64M | 20.85M | 15.50M | 12.10M | 8.20M | |||
| Accounts Payable | 2.70M | 3.12M | 1.10M | 4.00M | 2.60M | |||
| Other Current Liabilities | 3.82M | 4.33M | 11.40M | 9.80M | 1.00M | |||
| Total Current Liabilities | 32.16M | 28.30M | 28.10M | 25.80M | 12.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 900.00K | |||
| Deferred Taxes/Income | 557.00K | 557.00K | 400.00K | 500.00K | 200.00K | |||
| Other Non-Current Liabilities | 30.41M | 34.95M | 44.40M | 28.20M | 4.70M | |||
| Total Non-Current Liabilities | 30.97M | 35.51M | 44.80M | 28.70M | 5.80M | |||
| TOTAL LIABILITIES | 63.13M | 63.81M | 72.90M | 54.50M | 18.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -412.90M | -299.29M | -197.20M | -97.80M | -30.90M | |||
| Additional Paid In Capital | 693.30M | 667.65M | 499.60M | 485.70M | 7.40M | |||
| Common Shares | 9.00K | 8.00K | 0.00 | 0.00 | 41.30M | |||
| Other Shareholders' Equity | 789.00K | 30.00K | -1.50M | -100.00K | N/A | |||
| Shares Outstanding | 90.55M | 88.45M | 61.00M | 60.30M | 56.70M | |||
| Tangible Book Value per Share | 3.11 | 4.17 | 4.93 | 6.43 | -0.41 | |||
| Total Shareholders' Equity | 281.20M | 368.40M | 300.90M | 387.80M | 17.90M | |||
| TOTAL LIABILITIES AND EQUITY | 344.33M | 432.21M | 373.80M | 442.40M | 36.00M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.05 | |||
| Current Ratio | 7.38 | 11.97 | 9.26 | 15.16 | 1.96 | |||
| Return On Assets (ROA) | -43.02% | -23.62% | -26.60% | -15.13% | -95.31% | |||
| Return On Equity (ROE) | -52.67% | -27.71% | -33.04% | -17.26% | -191.68% | |||
All data in USD , ROIC based on taxRate of 0.21